We are live on ! Find out more
SPC

Sigma Planning Corp Portfolio holdings

AUM $3.6B
1-Year Est. Return 24.57%
This Fund
S&P 500
This Quarter Est. Return
+6.26%
1 Year Est. Return
+24.57%
3 Year Est. Return
+69.88%
5 Year Est. Return
+82.98%
10 Year Est. Return
+301.75%
AUM
$2.78B
AUM Growth
-$224M
Cap. Flow
-$352M
Cap. Flow %
-12.63%
Top 10 Hldgs %
22.87%
Holding
1,382
New
87
Increased
311
Reduced
775
Closed
179

Sector Composition

Rank Sector Weight
1 Technology 11.77%
2 Consumer Discretionary 4.93%
3 Healthcare 4.39%
4 Financials 4.02%
5 Industrials 3.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ONB icon
1126
Old National Bancorp
ONB
$10.1B
$147K 0.01%
10,558
+7
+0.1% +$93
MDNA
1127
DELISTED
Medicenna Therapeutics Corp. Common Shares
MDNA
$147K 0.01%
305,300
+3,250
+1% +$2.01K
CMLS
1128
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
$144K 0.01%
35,205
+8,583
+32% +$28.8K
EZPW icon
1129
Ezcorp Inc
EZPW
$1.82B
$140K 0.01%
16,713
+1,729
+12% +$15K
PFN
1130
PIMCO Income Strategy Fund II
PFN
$695M
$139K 0.01%
+19,328
New +$137K
VALE icon
1131
Vale
VALE
$62.9B
$139K 0.01%
10,348
-56,551
-85% -$801K
DCGO icon
1132
DocGo
DCGO
$58.9M
$133K ﹤0.01%
14,200
CHS
1133
DELISTED
Chicos FAS, Inc.
CHS
$129K ﹤0.01%
24,170
KYNB
1134
Kyntra Bio
KYNB
$28.5M
$127K ﹤0.01%
1,878
+881
+88% +$364K
FSCO
1135
FS Credit Opportunities Corp
FSCO
$989M
$126K ﹤0.01%
26,535
+7,719
+41% +$34.2K
SER icon
1136
Serina Therapeutics
SER
$31M
$125K ﹤0.01%
3,972
+242
+6% +$5.18K
STEM icon
1137
Stem
STEM
$49.2M
$123K ﹤0.01%
1,078
+159
+17% +$15.8K
EDIT icon
1138
Editas Medicine
EDIT
$399M
$123K ﹤0.01%
14,967
+397
+3% +$3.46K
HLN icon
1139
Haleon
HLN
$43.1B
$121K ﹤0.01%
14,423
-5,738
-28% -$49K
FAX
1140
abrdn Asia-Pacific Income Fund
FAX
$590M
$119K ﹤0.01%
7,327
-436
-6% -$7.08K
VMO icon
1141
Invesco Municipal Opportunity Trust
VMO
$647M
$117K ﹤0.01%
12,397
-462
-4% -$4.37K
MTTR
1142
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
$113K ﹤0.01%
35,773
+2,891
+9% +$8.02K
NWL icon
1143
Newell Brands
NWL
$2.16B
$106K ﹤0.01%
12,238
-10,149
-45% -$101K
CHPT icon
1144
ChargePoint
CHPT
$133M
$106K ﹤0.01%
603
+48
+9% +$8.41K
TPIC
1145
DELISTED
TPI Composites
TPIC
$104K ﹤0.01%
10,060
-130
-1% -$1.46K
LTRN icon
1146
Lantern Pharma
LTRN
$35.1M
$102K ﹤0.01%
18,125
+850
+5% +$4.39K
QS icon
1147
QuantumScape Corp
QS
$3B
$102K ﹤0.01%
12,769
-2,820
-18% -$19.6K
CIM
1148
Chimera Investment
CIM
$1.05B
$91.4K ﹤0.01%
5,279
-3,405
-39% -$54.2K
VTNR
1149
DELISTED
Vertex Energy, Inc
VTNR
$89.7K ﹤0.01%
14,350
-50
-0.3% -$352
HNRG icon
1150
Hallador Energy
HNRG
$718M
$85.7K ﹤0.01%
10,000

Similar funds

Sigma Planning Corp's Q2 2023 Portfolio in Review

As of Q2 2023, Sigma Planning Corp held 1,382 positions worth $2.78B, down 7.5% from $3.01B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sigma Planning Corp withdrew a net $352M in Q2 2023, closing 179 positions and reducing 775 holdings. Its most notable exit was Invesco S&P 500 Pure Value ETF, an estimated $2.68M position sold in full.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 10% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Sigma Planning Corp opened a new position in Pacer Swan SOS Fund of Funds ETF worth $5.12M.

  • Sigma Planning Corp's largest Q2 2023 buy was Pacer Swan SOS Fund of Funds ETF: 210,328 shares worth $5.12M.
  • Sigma Planning Corp added most to FT Vest US Equity Buffer ETF August in Q2 2023, an estimated $23.6M increase.
  • Sigma Planning Corp's biggest Q2 2023 reduction was First Trust Morningstar Dividend Leaders Index Fund, cutting an estimated $13M.
  • Sigma Planning Corp fully exited Invesco S&P 500 Pure Value ETF in Q2 2023, selling an estimated $2.68M.
  • Sigma Planning Corp's ten largest holdings make up 23% of its $2.78B portfolio in Q2 2023.
  • Sigma Planning Corp opened 87 new positions and closed 179 in Q2 2023.
  • Sigma Planning Corp's portfolio value fell 7.5% quarter-over-quarter to $2.78B.

Based on Sigma Planning Corp's 13F filing for Q2 2023, filed 2 Aug 2023.